At a glance
ClinicalIndex Comparison RecordN/ACompleted· 168 enrolled
Drug / intervention
Restylane Volymedevice
Likely dose
Restylane Volyme via subcutaneous injection (specific volume not stated)AI-extracted
Key inclusion· 4
- ✓Men or women aged 18 years or older of Chinese origin
- ✓Seeking augmentation therapy for the midface
- ✓MMVS score of 2, 3, or 4 on each side of the face as assessed by the blinded evaluator
- ✓Willing to abstain from other facial plastic surgical or cosmetic procedures below the lower orbital rim during the study
Key exclusion· 5
- ✕Known or previous allergy/hypersensitivity to hyaluronic acid gel, lidocaine, or amide-type local anesthetics
- ✕Previous surgery or tattoo in the treatment area
- ✕Previous permanent or semi-permanent facial fillers, autologous fat, lifting threads, or permanent implants below the lower orbital rim
- ✕Previous hyaluronic acid or collagen-based biodegradable fillers, or neurotoxins within 9 months before treatment
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Multi-center, Evaluator-blinded, No-treatment Controlled Study to Evaluate the Effectiveness and Safety of Restylane Volyme for Correction of Midface Volume Deficit and/or Midface Contour Deficiency
In Brief
A clinical study evaluating Restylane Volyme for Midface Volume Deficit. Completed, enrolled 168 participants across 1 site.
Detailed Summary
This is a randomized, evaluator-blinded, no-treatment controlled study in subjects with Midface Volume Deficit and/or Midface Contour Deficiency.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMidface Volume Deficit
CountriesChina
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedSep 2017
Enrollment StartDec 2017
Primary CompletionJan 2019
Study CompletionJul 2019
TodayJul 2026
First PostedSep 20, 2017
Enrollment StartDec 1, 2017
Primary CompletionJan 31, 2019
Study CompletionJul 31, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 8.8 years ago
Interventions
Restylane Volymedevice
Subcutis injection